Literature DB >> 35616855

Production of Recombinant Proteins in Transgenic Tobacco Plants.

Tim H Szeto1, Pascal M W Drake2, Audrey Y-H Teh1, Nicole Falci Finardi1, Ashleigh G Clegg1, Mathew J Paul1, Rajko Reljic1, Julian K-C Ma1.   

Abstract

Nicotiana tabacum (the tobacco plant ) has numerous advantages for molecular farming, including rapid growth, large biomass and the possibility of both cross- and self-fertilization. In addition, genetic transformation and tissue culture protocols for regeneration of transgenic plants are well-established. Here, we describe the production of transgenic tobacco using Agrobacterium tumefaciens and the analysis of recombinant proteins, either in crude plant extracts or after purification, by enzyme-linked immunosorbent assays, sodium dodecyl sulfate polyacrylamide gel electrophoresis with western blotting and surface plasmon resonance.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Agrobacterium tumefaciens; ELISA; Nicotiana tabacum; Recombinant protein; SDS PAGE; Surface plasmon resonance; Transgenic; Western blotting

Mesh:

Substances:

Year:  2022        PMID: 35616855     DOI: 10.1007/978-1-0716-2241-4_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  37 in total

Review 1.  The production of recombinant pharmaceutical proteins in plants.

Authors:  Julian K-C Ma; Pascal M W Drake; Paul Christou
Journal:  Nat Rev Genet       Date:  2003-10       Impact factor: 53.242

2.  Recombinant protein production in a variety of Nicotiana hosts: a comparative analysis.

Authors:  Andrew J Conley; Hong Zhu; Linda C Le; Anthony M Jevnikar; Byong H Lee; Jim E Brandle; Rima Menassa
Journal:  Plant Biotechnol J       Date:  2010-10-08       Impact factor: 9.803

3.  Production of antibodies in transgenic plants.

Authors:  A Hiatt; R Cafferkey; K Bowdish
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

Review 4.  Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?

Authors:  Pascal M W Drake; Tim H Szeto; Mathew J Paul; Audrey Y-H Teh; Julian K-C Ma
Journal:  Br J Clin Pharmacol       Date:  2016-07-28       Impact factor: 4.335

Review 5.  The emergence of antibody therapies for Ebola.

Authors:  Andrew Hiatt; Michael Pauly; Kevin Whaley; Xiangguo Qiu; Gary Kobinger; Larry Zeitlin
Journal:  Hum Antibodies       Date:  2015-12-23

6.  Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.

Authors:  Julian K-C Ma; Jürgen Drossard; David Lewis; Friedrich Altmann; Julia Boyle; Paul Christou; Tom Cole; Philip Dale; Craig J van Dolleweerd; Valerie Isitt; Dietmar Katinger; Martin Lobedan; Hubert Mertens; Mathew J Paul; Thomas Rademacher; Markus Sack; Penelope A C Hundleby; Gabriela Stiegler; Eva Stoger; Richard M Twyman; Brigitta Vcelar; Rainer Fischer
Journal:  Plant Biotechnol J       Date:  2015-07-03       Impact factor: 9.803

Review 7.  Molecular pharming's foot in the FDA's door: Protalix's trailblazing story.

Authors:  Tsafrir S Mor
Journal:  Biotechnol Lett       Date:  2015-07-07       Impact factor: 2.461

8.  Optimisation of contained Nicotiana tabacum cultivation for the production of recombinant protein pharmaceuticals.

Authors:  Richard Colgan; Christopher J Atkinson; Matthew Paul; Sally Hassan; Pascal M W Drake; Amy L Sexton; Simon Santa-Cruz; David James; Keith Hamp; Colin Gutteridge; Julian K-C Ma
Journal:  Transgenic Res       Date:  2009-07-09       Impact factor: 2.788

9.  Molecular farming in tobacco hairy roots by triggering the secretion of a pharmaceutical antibody.

Authors:  Suvi T Häkkinen; Nicole Raven; Maurice Henquet; Marja-Leena Laukkanen; Tibor Anderlei; Juha-Pekka Pitkänen; Richard M Twyman; Dirk Bosch; Kirsi-Marja Oksman-Caldentey; Stefan Schillberg; Anneli Ritala
Journal:  Biotechnol Bioeng       Date:  2013-09-24       Impact factor: 4.530

10.  Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins.

Authors:  Stefan Schillberg; Nicole Raven; Holger Spiegel; Stefan Rasche; Matthias Buntru
Journal:  Front Plant Sci       Date:  2019-06-11       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.